Facility Design and Engineering

Oct 23, 2017
By Pharmaceutical Technology Editors
The $72-million investment, part of a larger $850-million investment into its US operations, will allow the drugmaker to replace an outdated insulin vial-filling line and to upgrade technology at its Indianapolis manufacturing plant.
Oct 20, 2017
By Pharmaceutical Technology Editors
The company has announced that it has acquired a new bioanalysis and biomarkers services facility in Laval, Montreal, Canada to support preclinical and clinical programs.
Oct 18, 2017
By Pharmaceutical Technology Editors
The partnership and the formation of the institute intend to bring together industry, academia, and regulators to tackle challenges and provide solutions for continuous manufacturing.
Oct 18, 2017
Equipment and Processing Report
Water shortages, testing, and effluent treatment are important issues for pharma manufacturers.
Oct 16, 2017
By Pharmaceutical Technology Editors
The company announced plans to expand its viral vector process development facilities in the United States and its cleanroom facilities in the Netherlands for vector-based products.
Oct 16, 2017
By Pharmaceutical Technology Editors
The new center will serve as a regional hub where scientists and engineers can work with customers for biological development.
Oct 12, 2017
By Pharmaceutical Technology Editors
The company is investing EUR 170 million (US$201 million) to expand its vaccine manufacturing site in France for its newest influenza vaccine.
Oct 11, 2017
By Pharmaceutical Technology Editors
Johnson & Johnson’s Janssen Sciences Ireland UC will invest more than EUR 300 million (US$355 million) to expand manufacturing capacity for biologic medicines at its Ireland facility.
Oct 06, 2017
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Cytel, a biometrics CRO and clinical trial software provider, announced that it will be adding a new location for clinical development in Basel, Switzerland.
Oct 04, 2017
By Pharmaceutical Technology Editors
The iCON brand aims to offer flexible, rapidly deployable systems for biopharmaceutical manufacturing.
native1_300x100
lorem ipsum